Publikationen in Zusammenarbeit mit Forschern von Peking University (2)

2018

  1. Minimal residual disease status predicts outcome of acute myeloid leukaemia patients undergoing T-cell replete haploidentical transplantation. An analysis from the Acute Leukaemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

    British Journal of Haematology, Vol. 183, Núm. 3, pp. 411-420

2017

  1. Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus-host disease prophylaxis in haploidentical transplant

    Haematologica, Vol. 102, Núm. 2, pp. 401-410